YouTube Facebook LinkedIn Google+ Twitter Xingrss  

Roche Bids Again for Illumina?


December 21, 2012 | A Swiss newspaper is reporting that Roche and Illumina may have come to a purchase agreement, eight months after Illumina rejected Roche's last proposed bid. The two companies will announce a January $66/share sale price, the paper reported, though it said the information couldn't be verified. Analysts are very skeptical and neither company will comment. Bloomberg 

Update: Matthew Herper at Forbes contends that if Roche is bidding again for Illumina, Jay Flatley, Illumina's CEO, is the main asset. Forbes

View Next Related Story
Illumina at EmTech | Sep 25, 2014
Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1


For reprints and/or copyright permission, please contact  Terry Manning, 781.972.1349 , tmanning@healthtech.com.